Olmesartan Medoxomil E Amlodipina Accord (Olmesartan Medoxomil, Amlodipine)

Olmesartan Medoxomil E Amlodipina Accord combines an ARB with a calcium‑channel blocker to address the renin‑angiotensin system and vascular tone pathways.

• Hypertension: Improves blood pressure control when monotherapy is insufficient.
• Hypertension with isolated systolic hypertension: Provides additional systolic pressure reduction.
• Hypertension in patients with metabolic syndrome: Offers effective BP lowering with a favorable metabolic profile.

• Olmesartan medoxomil blocks the binding of angiotensin II to the AT1 receptor on vascular smooth‑muscle cells, preventing vasoconstriction and aldosterone release. Amlodipine inhibits calcium influx through L‑type channels in arterial smooth‑muscle, causing dose‑dependent vasodilation. The combined effect produces additive blood‑pressure reduction.

Adverse reactions may occur with any antihypertensive regimen.

Common Side Effects

• Dizziness or light‑headedness
• Headache
• Peripheral edema
• Flushing
• Fatigue
• Nasal congestion

Serious or Rare Side Effects

• Angio‑edema
• Severe hypotension
• Hepatic enzyme elevation
• Acute kidney injury
• Myocardial infarction in rare cases
• Severe allergic reactions (anaphylaxis)

Use of this combination requires careful clinical assessment and monitoring.

• Blood pressure monitoring: Check BP regularly to avoid excessive lowering.
• Renal function: Assess baseline kidney function and adjust if needed.
• Hepatic function: Monitor liver enzymes in patients with liver disease.
• Electrolyte balance: Observe potassium and sodium levels, especially if used with diuretics.
• Pregnancy: Contra‑indicated in the second and ​  ​  ​  ​   ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ‑  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​
• Breastfeeding: Weigh benefits against potential infant exposure.
• Drug interactions: Review concomitant antihypertensives and potassium‑sparing agents.
• Store at  

-   -  

• The